Newborn affected by maternal use of sedative-hypnotics

This code signifies a newborn experiencing adverse effects due to the mother's antenatal use of sedative-hypnotic medications. These effects can manifest as withdrawal symptoms, respiratory depression, hypotonia, or other neurological or physiological disturbances observed in the neonate. It indicates a direct impact on the newborn's health status attributable to maternal substance exposure.

Apply this code when documentation clearly indicates a newborn's condition is a direct consequence of maternal sedative-hypnotic use during pregnancy. This includes cases of neonatal abstinence syndrome (NAS) specifically linked to these drug classes, or other documented adverse effects. Supporting documentation should specify the maternal substance use and the resulting neonatal symptoms or diagnoses.

• Always sequence this code as a secondary diagnosis, following the code for the specific condition or symptom exhibited by the newborn (e.g., neonatal abstinence syndrome).
• Ensure documentation specifies "sedative-hypnotics" as the maternal substance; avoid using for other drug classes.
• Do not use if the maternal drug use is recreational and not prescribed; refer to codes for maternal abuse of drugs.